FY24 revenue $8M. For the full year of 2025, the Company expects low double-digit percentage revenue growth, with the main catalyst being the higher margin Population Health and Behavioral and Mental Health business units. Based on efficiency gains exiting 2024, the Company expects to continue its trend towards profitability. Guidance does not include any potential revenues from two federal contracts announced in early 2024.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYRA:
- Syra Health Corp. Class A (SYRA) Q4 Earnings Cheat Sheet
- Syra Health granted $450K contract extension in Shelby County, Tennessee
- Syra Health announces preliminary results on Syrenity
- Syra Health awarded six-month, $135,000 contract with Midwest-based university
- Syra Health files $75M mixed securities shelf
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue